These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36066075)

  • 1. Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.
    Young CA; Ealing J; McDermott CJ; Williams TL; Al-Chalabi A; Majeed T; Talbot K; Harrower T; Faull C; Malaspina A; Annadale J; Mills RJ; Tennant A;
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):82-90. PubMed ID: 36066075
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence, treatment and correlates of depression in multiple sclerosis.
    Young CA; Langdon D; Rog D; Chhetri SK; Tanasescu R; Kalra S; Webster G; Nicholas R; Ford HL; Woolmore J; Paling D; Tennant A; Mills R;
    Mult Scler Relat Disord; 2024 Jul; 87():105648. PubMed ID: 38713965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms of anxiety and depression in patients with amyotrophic lateral sclerosis and their relatives during the disease trajectory.
    Larsson BJ; Nordin K; Nygren I
    J Neurol Sci; 2023 Dec; 455():122780. PubMed ID: 37976792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
    Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Harrower T; Orrell RW; Annadale J; Hanemann CO; Scalfari A; Tennant A; Mills R;
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):475-485. PubMed ID: 38465877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of depression in a 12-month consecutive sample of patients with ALS.
    Wicks P; Abrahams S; Masi D; Hejda-Forde S; Leigh PN; Goldstein LH
    Eur J Neurol; 2007 Sep; 14(9):993-1001. PubMed ID: 17718691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature.
    Edge R; Mills R; Tennant A; Diggle PJ; Young CA;
    J Neurol; 2020 Mar; 267(3):607-615. PubMed ID: 31696295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis.
    Caga J; Ramsey E; Hogden A; Mioshi E; Kiernan MC
    Palliat Support Care; 2015 Aug; 13(4):1019-24. PubMed ID: 25137152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads.
    Burke T; Hardiman O; Pinto-Grau M; Lonergan K; Heverin M; Tobin K; Staines A; Galvin M; Pender N
    J Neurol; 2018 Apr; 265(4):793-808. PubMed ID: 29396678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management.
    Kurt A; Nijboer F; Matuz T; Kübler A
    CNS Drugs; 2007; 21(4):279-91. PubMed ID: 17381183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis.
    Young C; Ealing J; McDermott C; Williams T; Al-Chalabi A; Majeed T; Roberts R; Mills R; Tennant A;
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):390-398. PubMed ID: 34709092
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease.
    Young CA; Ealing J; McDermott C; Williams T; Al-Chalabi A; Majeed T; Burke G; Pinto A; Dick D; Talbot K; Harrower T; Walsh J; Chandran S; Hanemann CO; Mills R; Tennant A
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):317-327. PubMed ID: 31116037
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders.
    Taylor L; Wicks P; Leigh PN; Goldstein LH
    Eur J Neurol; 2010 Aug; 17(8):1047-53. PubMed ID: 20158515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep disorders in amyotrophic lateral sclerosis: A questionnaire-based study from India.
    Panda S; Gourie-Devi M; Sharma A
    Neurol India; 2018; 66(3):700-708. PubMed ID: 29766929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and bulbar involvement in amyotrophic lateral sclerosis.
    Hillemacher T; Grässel E; Tigges S; Bleich S; Neundörfer B; Kornhuber J; Hecht MJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):245-9. PubMed ID: 15799555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Incidence, and Clinical-Epidemiological Characterization of Amyotrophic Lateral Sclerosis in Antioquia: Colombia.
    Zapata-Zapata CH; Franco Dáger E; Aguirre-Acevedo DC; de Carvalho M; Solano-Atehortúa J
    Neuroepidemiology; 2020; 54(3):251-257. PubMed ID: 31812965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding depression with amyotrophic lateral sclerosis: a short assessment of facts and perceptions.
    Jellinger KA
    J Neural Transm (Vienna); 2024 Feb; 131(2):107-115. PubMed ID: 37922093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spanish adaptation and validation of the ALS Depression Inventory-12 (ADI-12) in patients with Amyotrophic Lateral Sclerosis.
    Sancho-Cantus D; Cubero-Plazas L; Privado J; García-Iturrospe EJA; Cañabate Ros M; Navarro-Illana E; Ortí JER
    Arch Med Res; 2024 Jan; 55(1):102936. PubMed ID: 38141272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial.
    Pagnini F; Marconi A; Tagliaferri A; Manzoni GM; Gatto R; Fabiani V; Gragnano G; Rossi G; Volpato E; Banfi P; Palmieri A; Graziano F; Castelnuovo G; Corbo M; Molinari E; Riva N; Sansone V; Lunetta C
    Eur J Neurol; 2017 Apr; 24(4):578-586. PubMed ID: 28229508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.
    Chiò A; Logroscino G; Traynor BJ; Collins J; Simeone JC; Goldstein LA; White LA
    Neuroepidemiology; 2013; 41(2):118-30. PubMed ID: 23860588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.